Ajanta Pharma Limited
AJANTPHARM
Rang in aandelen
#3727
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Aandeelprijs
$35.98
Marktkapitalisatie
$4.50B
Verandering (1 dag)
-1.18%
Verandering (1 jaar)
29.38%
Land
IN
Handel Ajanta Pharma Limited (AJANTPHARM)
Categorie
Healthcare
Omzet van Ajanta Pharma Limited (AJANTPHARM)
Omzet in Jun 2026 TTM: $637.45M
Volgens de laatste financiële rapporten van Ajanta Pharma Limited bedraagt de huidige omzet van het bedrijf (TTM) $637.45M. In 2024 behaalde het bedrijf een omzet van $504.74M een stijging ten opzichte van de omzet in het jaar 2023, die $455.42M bedroeg. De omzet is het totale bedrag aan inkomsten dat een bedrijf genereert door de verkoop van goederen of diensten. In tegenstelling tot de winst worden er geen kosten afgetrokken.
Omzetgeschiedenis van Ajanta Pharma Limited van 2005 tot 2026
Omzet aan het einde van elk jaar
| Jaar | Omzet | Wijzigen |
|---|---|---|
| 2026 (TTM) | $637.45M | 17.29% |
| 2025 | $543.47M | 7.67% |
| 2024 | $504.74M | 10.83% |
| 2023 | $455.42M | 5.26% |
| 2022 | $432.64M | 11.24% |
| 2021 | $388.92M | 14.37% |
| 2020 | $340.05M | 17.10% |
| 2019 | $290.39M | -8.20% |
| 2018 | $316.32M | 7.04% |
| 2017 | $295.52M | 14.66% |
| 2016 | $257.74M | 10.53% |
| 2015 | $233.19M | 18.34% |
| 2014 | $197.05M | 16.14% |
| 2013 | $169.67M | 27.01% |
| 2012 | $133.59M | 17.92% |
| 2011 | $113.29M | 24.79% |
| 2010 | $90.78M | 31.92% |
| 2009 | $68.81M | -10.99% |
| 2008 | $77.31M | 29.89% |
| 2007 | $59.52M | 15.41% |
| 2006 | $51.57M | 13.41% |
| 2005 | $45.48M | 0.00% |
Omzet van vergelijkbare bedrijven of concurrenten
| Bedrijf | Omzet | Omzetverschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 937.20% |
IN
|
